LENZ Therapeutics, Inc. (LENZ)
7.21
+0.56
(+8.42%)
USD |
NASDAQ |
May 20, 16:00
7.21
0.00 (0.00%)
After-Hours: 20:00
LENZ Therapeutics Cash from Investing (Quarterly) : 33.16M for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Maze Therapeutics, Inc. | 6.275M |
| CDT Equity, Inc. | 0.595M |
| Liminatus Pharma, Inc. | 0.00 |
| Oruka Therapeutics, Inc. | -14.44M |
| MapLight Therapeutics, Inc. | 67.01M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -33.58M |
| Cash from Financing (Quarterly) | 0.014M |
| Free Cash Flow | -87.44M |
| Free Cash Flow Per Share (Quarterly) | -1.072 |
| Free Cash Flow to Equity (Quarterly) | -33.46M |
| Free Cash Flow to Firm (Quarterly) | -33.60M |
| Free Cash Flow Yield | -40.75% |